{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-023947","form_type":"8-K","ticker":"IMMX","cik":"0001873835","company_name":"Immix Biopharma, Inc.","filed_at":"2024-06-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.042999+00:00","generated_at":"2026-06-01T04:26:30.103683+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Immix Biopharma shareholders approve 3M-share increase and evergreen provision in equity plan","bullets":["Shareholders approved increasing omnibus equity plan shares by 3,000,000 to 4,934,561 total.","Evergreen provision adopted: automatic annual increase of 5% of outstanding shares on Jan 1 for 10 years from 2025.","All eight director nominees elected; ratification of KMJ Corbin & Company LLP as auditor passed.","Meeting had 70.4% of shares present, constituting a quorum."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-023947","json":"https://secwatch.observer/filing/0001493152-24-023947.json","markdown":"https://secwatch.observer/filing/0001493152-24-023947.md","text":"https://secwatch.observer/filing/0001493152-24-023947.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1873835/000149315224023947/0001493152-24-023947-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1873835/000149315224023947/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:26:30.103683+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}